Liye Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
Papers in
- Oncology 11
- HER2/EGFR in Cancer Research 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Zuoxu Xie (6 shared papers)Bin Guo (3 shared papers)Gabriel Tao (1 shared paper)Kwang Bog Cho (1 shared paper)Yan Li (1 shared paper)Shuang Zhou (2 shared papers)Meiyan Sun (4 shared papers)Yue Zhou (2 shared papers)
- Journals
- Evidence-based Complementary and Alternative Medicine (2 papers)International Journal of Molecular Sciences (2 papers)Frontiers in Oncology (2 papers)Neurological Research (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesNew Zealand
In The Last Decade
Liye Wang
45 papers receiving 1.1k citations
Liye Wang's Hit Papers
Peers
Comparison fields: 5 of 130
- Cancer Research 483
- Molecular Biology 506
- Health Informatics 9
- Oncology 136
- Radiology, Nuclear Medicine and Imaging 109
Countries citing papers authored by Liye Wang
This map shows the geographic impact of Liye Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liye Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liye Wang more than expected).
Fields of papers citing papers by Liye Wang
This network shows the impact of papers produced by Liye Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liye Wang. The network helps show where Liye Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Liye Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long Noncoding RNA (lncRNA)-Mediated Competing Endogenous RNA Networks Provide Novel Potential Biomarkers and Therapeutic Targets for Colorectal Cancer Hit paper breakdown → | 2019 | 470 |
| 2 | 2023 | 67 | |
| 3 | 2020 | 67 | |
| 4 | 2021 | 56 | |
| 5 | 2020 | 54 | |
| 6 | 2014 | 34 | |
| 7 | 2020 | 30 | |
| 8 | 2020 | 25 | |
| 9 | 2021 | 23 | |
| 10 | 2021 | 19 | |
| 11 | 2021 | 17 | |
| 12 | 2022 | 17 | |
| 13 | 2011 | 15 | |
| 14 | 2018 | 14 | |
| 15 | 2014 | 14 | |
| 16 | 2020 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2012 | 11 | |
| 20 | 2021 | 10 |
About Liye Wang
Liye Wang is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Breast Cancer Treatment Studies (3 papers), Cancer-related molecular mechanisms research (3 papers), Neurological Disease Mechanisms and Treatments (3 papers), Inflammatory mediators and NSAID effects (3 papers) and COVID-19 diagnosis using AI (2 papers). The work is most often cited by research in Cancer Research (483 citations), Molecular Biology (506 citations), Health Informatics (9 citations), Oncology (136 citations) and Radiology, Nuclear Medicine and Imaging (109 citations). Liye Wang has collaborated with scholars based in China, United States and New Zealand. Frequent co-authors include Zuoxu Xie, Bin Guo, Gabriel Tao, Kwang Bog Cho, Yan Li, Shuang Zhou, Meiyan Sun, Yue Zhou, Hao Wang and Yan Li. Their work appears in journals such as Evidence-based Complementary and Alternative Medicine, International Journal of Molecular Sciences, Frontiers in Oncology, Neurological Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.